TiH MORBID ANATOMY of rheumatic mitral disease is such that in many instances nothing short of excision and replacement will allow adequate relief of the hemodynamic abnormality. Experience with eight such patients in whom mitral replacement has been performed with a ball-valve prosthesis forms the basis of this report.
Considerable work has been performed by other investigators in the development of a total mitral prosthesis for the dog and experience with human mitral replacement prior to our own attempts have been recorded. In 
Prosthesis
The experience of this laboratory with mitral replacement in the dog reported elsewhere 14, 15 led to the development of the ball valve prosthesis shown in Figure 1 from which all subsequent valves in this * Presented before the American Surgical Association, Boca Raton, Florida, March 21-23, 1961. This work is supported in part by a grant-in-aid from the Oregon Heart Association.
series have evolved. Firm and lasting fixation has been achieved by the use of interrupted sutures placed through the mitral annulus and through a knitted Teflon cloth ring to which the prosthesis is attached as shown in Figure 2 . Satisfactory hydraulic function in the dog was demonstrated by left atrial pressure tracings immediately following implantation ( Fig. 3 ) and by postoperative cardiac catheterization, angiocardiography, and cine-angiocardiography performed from two to 12 months following implantation. Some of the valves in the long-term survivor group have radio-opaque balls or steel pins inserted into the balls so that valve function and ball spin have been observed with fluoroscopy. The prosthesis currently employed in the human and the relative dimensions of the two sizes are pictured in Figure 4 . A cutaway drawing of the construction is depicted in Figure 5 . The case is cast in one piece stainless steel Table 2 .
Operative Technics With the patient in the full lateral position exposure is obtained through the entire right fifth intercostal space (Fig. 6) In the extensively calcified valve the junction of leaflet with annulus is not clear and it is therefore safer to achieve mobility of the valve prior to resection by dividing the chordae tendineae first (Fig. 8B ). The motion of the leaflet thereby achieved allows clear definition of the junction of the valve with annulus and division of the attached margins can follow with safety.
Following resection and inspection of the left ventricle for loose debris one of the two sizes of prostheses is selected and placed in the annulus for a direct fitting. The margins of the Teflon cloth ring must fit easily into the valve orifice and it is best to err on the side of the smaller prosthesis when in doubt. The selected valve is then removed from the heart and 0-silk sutures are placed through the mitral annulus and the cloth margin of the prosthesis. To avoid confusion these are placed through the anterior and posterior commissure first and the remaining sutures inserted one quadrant at a time, using three to four sutures within each quadrant (Fig. 9) (Fig. 11) . (Fig. 13, 14) .
Phonocardiography was performed on the surviving patients and confirmed the absence of murmurs due to mitral disease. A typical phonocardiogram before and after replacement is shown in Figure 15 . Kay, Muller and others have worked on it. They found that the great problem was not that they could not put in valves that would work, but that they always produced thrombi in dogs. This was true particularly at the junction between the myocardium or endocardium and the prosthetic substance. On the left side if these thrombi dropped off, the animal died of a cerebral embolism, and this inevitably took place within three or four weeks.
For that reason, many of us have been very reticent about putting in these artificial protheses. We have been waiting for the time when we thought we had to do it; but Dr. Starr has succeeded in doing it, and he has proved the point that was brought out at the NIH meeting in Chicago last fall concerning artificial heart valves, that probably man does not react as violently as the animal does in producing a clot at the interference between myocardium and the artificial prosthesis. It may be that man is a better candidate for this type of thing than the animal.
DR. ALBERT STARR: (Closing) We were prejudiced against the ball valve for use as an intracardiac prosthesis, and it was difficult to state in the short presentation the various steps that led to the choice of this "repugnant" intracardiac appliance.
Numerous other types of valves were tried, and as Dr. Clowes has mentioned, the problem of thrombosis in the dog made evaluation impossible. However, with the ball-valve prosthesis it was possible to obtain long-term dog survivors without anticoagulant treatment. I believe the reason for this is that the valvular mechanism is not attached to the body of the prosthesis itself. The clot in the dog grows by direct extension like an infiltrating tumor rather than by multicentric origin, so that the clot which forms on the margin of the valve at its point of attachment is less likely to interfere with valve function with the ball valve as compared with other types of prosthesis in which leaflets are anchored to the mitral annulus itself. I think this explains our ability to obtain long-term survival with the dog with the ball valve.
Some of the dogs who were not on anticoagulant treatment have had embolic problems requiring on one occasion reoperation for saddle emboli. For 
